Advertisements

GlycoMimetics Inc. (GLYC) Stock Quote

Detailed Quote for GlycoMimetics Inc. (GLYC)
$ 10.21 0.00 (0.00%) Volume: 0 4:00 PM EDT Aug 22, 2017
Today 5d 1m 3m 1y more
Last Price
10.21
Change $
Change %
Tick
  
Bid
10.10
Bid Size
1,000
Ask
11.70
Ask Size
300
Open
N/A
High
N/A
Low
N/A
Prev Close
10.21
Last Trade
08/22/17
Volume
0
52 Wk Hi
16.9400005
52 Wk Low
3.81999993
Market Cap
334.1m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
32,723,045
EPS (TTM)
-1.34000003
PE Ratio
N/A
Exchange
NSD
News and Media for GlycoMimetics Inc. (GLYC)
Sector News | Topic News
News for GlycoMimetics Inc. (GLYC)
Tue, Aug 22, 2017
11:05 AM GlycoMimetics's Year-To-Date Runup Is Just The Beginning - SeekingAlpha
Sat, Aug 19, 2017
9:00 AM Stocks to watch next week - SeekingAlpha
Thu, Aug 03, 2017
9:15 AM GlycoMimetics Reports Program Updates and Second Quarter 2017 Results - Business Wire
Tue, Jul 25, 2017
3:11 PM Biotech Bonanza: The Next Leg Up - SeekingAlpha
Wed, Jul 12, 2017
8:02 AM MyoKardia Brings Hope To Hypertrophic Cardiomyopathy - SeekingAlpha
Mon, Jul 10, 2017
12:20 PM Biotech Forum Daily Digest - IPO Activity Increasing, Spotlight On Flexion Therapeutics - SeekingAlpha
Thu, Jul 06, 2017
9:00 AM GlycoMimetics to Receive European Patent for GMI-1271 - Business Wire
Wed, Jun 28, 2017
11:54 AM Will The Federal Reserve Avoid A Slowdown? - SeekingAlpha
Fri, Jun 23, 2017
12:46 PM Midday Gainers / Losers - SeekingAlpha
Wed, Jun 21, 2017
1:58 PM Biotech's Best Chance Has Gotten Even Better - SeekingAlpha
Wed, Jun 14, 2017
8:50 AM GlycoMimetics Remains Undervalued After Leukemia Trial News - SeekingAlpha
Mon, Jun 12, 2017
9:00 AM GlycoMimetics Appoints Boston Biomedical CEO Patricia S. Andrews to Its Board of Directors - Business Wire
Mon, Jun 05, 2017
5:35 PM After Hours Gainers / Losers - SeekingAlpha
4:00 PM GlycoMimetics to Present at Jefferies 2017 Global Healthcare Conference - Business Wire
12:46 PM Midday Gainers / Losers - SeekingAlpha
7:00 AM GlycoMimetics Presents Updated Data from Ongoing Phase 1/2 Clinical Trial of GMI-1271 in Patients with Acute Myeloid Leukemia at ASCO 2017 Annual Meeting - Business Wire
Wed, May 31, 2017
9:20 AM Premarket Gainers as of 9:05 am - SeekingAlpha
9:00 AM GlycoMimetics Completes Enrollment of Relapsed/Refractory AML Patient Cohort in Phase 2 Portion of Clinical Trial of GMI-1271 - Business Wire
12:34 AM 3 Things In Biotech You Should Learn Today: May 30, 2017 - SeekingAlpha
Tue, May 30, 2017
5:38 PM After Hours Gainers / Losers - SeekingAlpha
More News for GLYC >>

Tags for GlycoMimetics Inc.

Research stocks or mutual funds related to GlycoMimetics Inc. by keywords or tags. Find companies that have a similar focus to GLYC. The keywords below have been associated to GLYC by either user submission or electronic means.